ResearcherMedical University of ViennaNo recent work listed
Ahmed Ba‐Ssalamah
Matched on ORCID iD 0000-0002-3527-404X; OpenAlex author ID A5062078348. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2011: 2 papers · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 5
- [Chronic pancreatitis : Characterization and differentiation from pancreatic cancer]. Last author DOI 10.1007/s00117-021-00857-9↗
- Objective and subjective comparison of virtual monoenergetic vs. polychromatic images in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00330-019-06116-9↗
- A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer. Co-author PMID 24778046↗
- NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer. Last author DOI 10.1016/j.surg.2010.07.048↗
- Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cance… First author DOI 10.1148/radiol.11101189↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Antonia Kristic · 1 shared paper, 2021 · strength 0.15
- Martin Schindl · 2 shared papers, 2014–2019 · strength 0.14
- Paper Objective and subjective comparison of virtual monoenergetic vs. polychromatic images in patients with pancreatic ducta… DOI 10.1007/s00330-019-06116-9↗
- Paper A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced p… PMID 24778046↗
- Paul Apfaltrer · 1 shared paper, 2019 · strength 0.10
- Lucian Beer · 1 shared paper, 2019 · strength 0.10
- Klaus Sahora · 3 shared papers, 2011–2014 · strength 0.09
- Paper A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced p… PMID 24778046↗
- Paper Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patie… DOI 10.1148/radiol.11101189↗
- Paper NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer. DOI 10.1016/j.surg.2010.07.048↗
- Gregor Werba · 1 shared paper, 2014 · strength 0.04
- Michael Gnant · 1 shared paper, 2014 · strength 0.04
- Claus Koelblinger · 1 shared paper, 2011 · strength 0.03
- Wolfgang Schima · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.